Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 19/20 | 0.66 |
| ▸ | MMP2 | P08253 | 16/20 | 0.66 |
| ▸ | MMP1 | P03956 | 7/20 | 0.66 |
| ▸ | MMP3 | P08254 | 3/20 | 0.66 |
| ▸ | MMP13 | P45452 | 3/20 | 0.66 |
| ▸ | MMP7 | P09237 | 1/20 | 0.66 |
| ▸ | MMP8 | P22894 | 1/20 | 0.66 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.40 |
| ▸ | MMP17 | Q9ULZ9 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7595400 | 0.95 | MMP9 (0.74) | MMP9MMP2MMP1MMP3MMP13 | |
| SCHEMBL7595412 | 0.95 | MMP9 (0.74) | MMP9MMP2MMP1MMP3MMP13 | |
| SCHEMBL7491059 | 0.85 | MMP9 (0.67) | MMP9MMP2MMP1MMP3MMP13 | |
| SCHEMBL7595948 | 0.84 | MMP9 (0.80) | MMP9MMP2MMP1MMP3MMP13 | |
| SCHEMBL7595943 | 0.84 | MMP9 (0.80) | MMP9MMP2MMP1MMP3MMP13 | |
| SCHEMBL7596477 | 0.83 | MMP9 (0.80) | MMP9MMP2MMP1MMP3MMP13 | |
| SCHEMBL7425780 | 0.83 | MMP9 (0.80) | MMP9MMP2MMP1MMP3MMP13 | |
| SCHEMBL7596470 | 0.83 | MMP9 (0.80) | MMP9MMP2MMP1MMP3MMP13 | |
| SCHEMBL7597601 | 0.83 | MMP9 (0.80) | MMP9MMP2MMP1MMP3MMP13 | |
| SCHEMBL7593933 | 0.82 | MMP9 (0.70) | MMP9MMP2MMP1MMP3MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1147101-B1 | REVERSE HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES | ABBOTT LAB (US) | 2002-11-20 | — | — | EP | claimed |
| EP-1147101-A1 | REVERSE HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES | ABBOTT LABORATORIES (US) | 2001-10-24 | — | — | EP | claimed |
| US-6294573-B1 | FOR THERAPY RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPENIAS SUCH AS OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL, EPIDERMAL OR GASTRIC ULCERATION, AND TUMOR GROWTH AND METASTASIS OR INVASION | ABBOTT LABORATORIES | 2001-09-25 | — | — | US | claimed |
| WO-2000044739-A1 | REVERSE HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES | ABBOTT LABORATORIES (US) | 2000-08-03 | — | — | WO | claimed |
| EP-1147101-B1 | REVERSE HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES | ABBOTT LAB (US) | 2002-11-20 | — | — | EP | disclosed |
| US-6294573-B1 | FOR THERAPY RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPENIAS SUCH AS OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL, EPIDERMAL OR GASTRIC ULCERATION, AND TUMOR GROWTH AND METASTASIS OR INVASION | ABBOTT LABORATORIES | 2001-09-25 | — | — | US | disclosed |